Ferrlecit

Sodium ferric gluconate complex

Sodium ferric gluconate complex

Add article description


Sodium ferric gluconate complex, sold under the brand name Ferrlecit, is an intravenously administered iron medication for the treatment of iron deficiency anemia in adults and in children aged six years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy.[1] The macromolecule has an apparent molecular weight of 289,000–440,000 Dalton.[2][3]

Quick Facts Clinical data, Trade names ...

The most common side effects in adults are nausea, vomiting and/or diarrhea, injection site reaction, hypotension, cramps, hypertension, dizziness, dyspnea, chest pain, leg cramps, and pain.[1] In children the most common side effects are hypotension, headache, hypertension, tachycardia and vomiting.[1]


References

  1. "Ferrlecit- sodium ferric gluconate complex injection". DailyMed. 25 September 2019. Retrieved 2 April 2020.
  2. "Sodium ferric gluconate complex". www.drugbank.ca. Retrieved 21 June 2020.[title missing]
  3. Fishbane S, Wagner J (May 2001). "Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis". American Journal of Kidney Diseases. 37 (5): 879–83. doi:10.1016/s0272-6386(05)80001-0. PMID 11325667.



Share this article:

This article uses material from the Wikipedia article Ferrlecit, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.